Trademark: 97920925
Word
NATCO
Status
Pending
Status Code
686
Status Date
Tuesday, March 19, 2024
Serial Number
97920925
Mark Type
4000
Filing Date
Thursday, May 4, 2023
Published for Opposition
Tuesday, March 19, 2024

Trademark Owner History
Natco Pharma USA LLC - Owner At Publication

Classifications
40 Custom manufacture of pharmaceuticals
5 Pharmaceutical preparations for the treatment of nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery, and containing ondansetron; Pharmaceutical preparations for the treatment of angina by sublingual administration, namely, nitroglycerin tablets
42 Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development

Trademark Events
Mar 19, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2024
Published For Opposition
Feb 28, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2024
Notification Of Notice Of Publication E-Mailed
Feb 19, 2024
Teas Change Of Correspondence Received
Feb 19, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 19, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 19, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 19, 2024
Teas Change Of Owner Address Received
Feb 9, 2024
Approved For Pub - Principal Register
Jan 30, 2024
Assigned To Examiner
Jun 4, 2023
New Application Office Supplied Data Entered
May 8, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24